Insights

Diversified Tech Stack UCB employs a modern analytics and operations technology footprint including Alteryx, Microsoft Power Apps, Qlik, Snowflake, Azure DevOps, BMC Remedy, Salesforce Service Cloud, and Sprout Social. This indicates a mature data and CRM environment with potential needs for system integrations, data governance, and automation enhancements to improve cross-functional workflows.

Global Presence With headquarters in Belgium and operations in nearly 40 countries, UCB presents opportunities for region-specific deployments, localization services, regulatory-compliant data streams, and vendor partnerships that support multi-market rollout and supply chain resilience.

Scale and Resources Employing 10,001+ people and reporting revenues above several billions suggests capacity for enterprise-level contracts, enterprise SaaS, security, and IT services, as well as potential needs for training, change management, and vendor support at scale.

Patient-Centric Value UCB emphasizes patient experiences and outcomes beyond medicine, signaling opportunities for partnerships in patient engagement platforms, digital health solutions, outcomes research, and value-based collaboration tools that align with their mission.

Strategic Partnerships Recent market movements and large-scale strategic actions in the broader sector imply openness to partnerships around data analytics, AI-driven insights, and cross-border regulatory-compliant solutions to support research, commercialization, and global operations.

Similar companies to UCB

UCB Tech Stack

UCB uses 8 technology products and services including Alteryx, Microsoft Power Apps, Qlik, and more. Explore UCB's tech stack below.

Media & News

UCB's Email Address Formats

UCB uses at least 4 email formats:
UCB Email FormatsExamplePercentage
First.Last@ucb.comJohn.Doe@ucb.com
93%
FLast@ucb.comJDoe@ucb.com
5%
First@ucb.comJohn@ucb.com
1%
Last.First@ucb.comDoe.John@ucb.com
1%

Frequently Asked Questions

What is UCB's phone number?

Minus sign iconPlus sign icon
You can contact UCB's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is UCB's stock symbol?

Minus sign iconPlus sign icon
UCB is a publicly traded company; the company's stock symbol is UCB.

What is UCB's official website and social media links?

Minus sign iconPlus sign icon
UCB's official website is ucb.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does UCB generate?

Minus sign iconPlus sign icon
As of August 2026, UCB's annual revenue is estimated to be $10B+.

What is UCB's SIC code and NAICS code?

Minus sign iconPlus sign icon
UCB's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does UCB have currently?

Minus sign iconPlus sign icon
As of August 2026, UCB has approximately 15K employees across 6 continents, including Europe, North America and Asia. Key team members include Chief Executive Officer: J. T., Cfo Ucb Ch (head Of Finance & Admin Ucb Switzerland) & Group Controller Corporate Functions: H. D. F. and Chief Information Security Officer: O. V. Explore UCB's employee directory with LeadIQ.

What industry does UCB belong to?

Minus sign iconPlus sign icon
UCB operates in the Pharmaceutical Manufacturing industry.

What technology does UCB use?

Minus sign iconPlus sign icon
UCB's tech stack includes Alteryx, Microsoft Power Apps, Qlik, Snowflake, Azure DevOps, BMC Remedy, Salesforce Service Cloud and Sprout Social.

What is UCB's email format?

Minus sign iconPlus sign icon
UCB's email format typically follows the pattern of First.Last@ucb.com. Find more UCB email formats with LeadIQ.

How much funding has UCB raised to date?

Minus sign iconPlus sign icon
As of August 2026, UCB has raised $202M in funding. The last funding round occurred on May 23, 2022 for $101M.

When was UCB founded?

Minus sign iconPlus sign icon
UCB was founded in 1928.
UCB logo

UCB

Pharmaceutical ManufacturingBrussels, Belgium10001+ Employees

UCB is a large global biopharmaceutical company headquartered in Brussels, Belgium, with operations in nearly 40 countries. It concentrates on therapies for severe central nervous system and immunological conditions, aiming to address disease burden beyond conventional medicines. The organization emphasizes learning from patients and caregivers to pursue innovations that affect daily life and long-term well-being.

Its approach centers on cross-border, cross-disciplinary collaboration with healthcare professionals, partners, and communities to shape research around patient needs. In June 2026, Brain Communications published findings on KYGEVVI therapy for TK2 deficiency, indicating improved survival and functional outcomes in treated patients.

Section iconCompany Overview

Phone number
Website
ucb.com
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
UCB
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1928
Employees
10001+

Section iconFunding & Financials

  • $202M

    UCB has raised a total of $202M of funding over 3 rounds. Their latest funding round was raised on May 23, 2022 in the amount of $101M as a Post IPO Equity.

  • $10B+

    UCB's revenue is estimated to be in the range of $10B+

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.